1-3 of 3
Hanne Due
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CDCA2 Is a Predictive Marker and Mediator of Bortezomib Response in Diffuse Large B-Cell Lymphoma

Hanne Due, Issa Ismail Issa, Martin Thomsen, Maja Zimmer Jakobsen, Hulda Haraldsdóttir, Rasmus Froberg Brøndum, Karen Dybkaer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1617.
https://doi.org/10.1182/blood-2023-173803
Published: 2023
Journal Articles

Addition of Drug-Response Specific Micro-RNAs to the International Prognostic Index Improves Prognostic Stratification of GCB-DLBCL Patients Treated with R-CHOP

Karen Dybkær, PhD, Hanne Due, MSc, Rasmus Froberg Brøndum, PhD, Ken H. Young, MD PhD, Martin Bøgsted, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1623.
https://doi.org/10.1182/blood-2019-122351
Published: 2019
Journal Articles

Beneficial Effect of Microrna-155 in Vincristine Response and Clinical Outcome in Especially GCB Diffuse Large B-Cell Lymphoma

Hanne Due, MSc, Anna Amanda Schönherz, PhD, Laura Barett Ryø, MSc, Anne Stidsholt Roug, MD Ass. Prof, Hans Erik Johnsen, MD Professor, Martin Bøgsted, Professor, Jacob Giehm Mikkelsen, Prof, Karen Dybkær, Professor
Journal: Blood
Blood (2017) 130 (Supplement 1): 2838.
https://doi.org/10.1182/blood.V130.Suppl_1.2838.2838
Published: 2017